Sponsor
Cantonal Hospital of St. Gallen
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Cantonal Hospital of St. Gallen appears in 32 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
32 shownFiber-Boost Randomized Controlled TrialNCT07483112 · lead sponsor · 2025-10-07
RECRUITINGDetermining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal AssessmentNCT06352710 · lead sponsor · 2023-06-12
RECRUITINGNevirapine / Lamivudine for HIV Maintenance TherapyNCT07014189 · lead sponsor · 2019-04-12
COMPLETEDThe Role of Physical Activity for Acute Exacerbations of COPDNCT03855670 · lead sponsor · 2018-11-29
COMPLETEDSmartphone Enabled Detection of Nocturnal Cough Rate and Sleep Quality as a Prognostic Marker for Asthma ControlNCT03635710 · lead sponsor · 2018-01-01
COMPLETEDNevirapine + 3TC Based Maintenance Therapy for HIV InfectionNCT03223402 · lead sponsor · 2016-12-23
COMPLETEDTelehealth Could Mitigate Disease Progression Compared to Standard of Care in COPD - a Randomized Controlled TrialNCT04485832 · lead sponsor · 2016-04-05
COMPLETEDDiagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CTNCT02468609 · lead sponsor · 2015-01-01
UNKNOWNThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECTNCT02050724 · lead sponsor · 2013-11-01
TERMINATEDNeurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With NatalizumabNCT01250678 · lead sponsor · 2011-01-01
UNKNOWNStudy Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple SclerosisNCT01250665 · lead sponsor · 2011-01-01
UNKNOWNRestoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass SurgeryNCT01271062 · lead sponsor · 2009-10-01
COMPLETEDCentral Nervous Processing of Visual Food Stimuli in Severely Obese SubjectsNCT01493583 · lead sponsor · 2009-09-01
COMPLETEDThe Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple SclerosisNCT00917839 · lead sponsor · 2009-06-01
UNKNOWNECG Triggered Dual Source CT for Non-invasive Pre-operative Cardiac Imaging in Morbid Obese PatientsNCT02802579 · lead sponsor · 2007-12-01
COMPLETEDHIV - Monotherapy in Switzerland (MOST-ch)NCT00531986 · lead sponsor · 2007-01-01
TERMINATEDDifferential Immune Effects of NatalizumabNCT00859482 · lead sponsor · 2006-07-01
COMPLETEDPhase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate CancerNCT01897207 · lead sponsor · 2002-11-01
COMPLETEDUltrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph NodesNCT06921681 · collaborator · 2025-03-07
RECRUITINGThe SwissPrEPared StudyNCT03893188 · collaborator · 2019-04-10
RECRUITINGSwiss Multiple Sclerosis Cohort-StudyNCT02433028 · collaborator · 2012-06-01
RECRUITINGSwiss Diabetes Registry - SwissDiab StudyNCT01179815 · collaborator · 2010-01-01
RECRUITINGDigital Delivery of Living Well With COPD for Patient Education and Self-management - a Mixed-method StudyNCT07031440 · collaborator · 2025-08-01
NOT_YET_RECRUITINGInfluence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer OutpatientsNCT04859400 · collaborator · 2021-06-07
COMPLETEDAtezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung CancerNCT03540420 · collaborator · 2018-07-31
ACTIVE_NOT_RECRUITING[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer ImagingNCT03242993 · collaborator · 2017-04-01
COMPLETEDAbiraterone-Rechallenge Study for CRPC PatientsNCT02656615 · collaborator · 2016-01-01
TERMINATEDA Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive IndividualsNCT02568332 · collaborator · 2015-07-21
COMPLETEDProstate Cancer BiobankNCT04024475 · collaborator · 2014-11-04
ACTIVE_NOT_RECRUITINGImmunogenicity and Safety of Vaccinations in Immunocompromised PersonsNCT01947465 · collaborator · 2013-10-01
COMPLETEDCentral European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug MonitoringNCT01326767 · collaborator · 2011-03-01
COMPLETEDCancer Development In Organ Transplant RecipientsNCT02333279 · collaborator · 2008-05-01
COMPLETEDDrugs studied in this sponsor's trials
3 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Cantonal Hospital of St. Gallen as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
abiraterone acetate1
atezolizumab1
lamotrigine1
Sponsor roles
lead sponsor18
collaborator14
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.